# A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland

> **NCT02289027** · PHASE1,PHASE2 · COMPLETED · sponsor: **Centre Hospitalier Universitaire Vaudois** · enrollment: 120 (actual)

## Conditions studied

- Ebola Vaccines

## Interventions

- **BIOLOGICAL:** cAd3-EBOZ vaccine
- **BIOLOGICAL:** Placebo (for cAd3-EBOZ vaccine)

## Key facts

- **NCT ID:** NCT02289027
- **Lead sponsor:** Centre Hospitalier Universitaire Vaudois
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2016-01-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02289027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02289027, "A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02289027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*